Article
Genome-wide association study of rate of cognitive decline in Alzheimer's disease patients identifies novel genes and pathways.
Alzheimer's & dementia : the journal of the Alzheimer's Association - 1 Aug 2020
Sherva Richard, Gross Alden, Mukherjee Shubhabrata, Koesterer Ryan, Amouyel Philippe, Bellenguez Celine, Dufouil Carole, Bennett David A, Chibnik Lori, Cruchaga Carlos, Del-Aguila Jorge, Farrer Lindsay A, Mayeux Richard, Munsie Leanne, Winslow Ashley, Newhouse Stephen, Saykin Andrew J, Kauwe John S K, Crane Paul K, Green Robert C
Abstract excerpt
INTRODUCTION: Variability exists in the disease trajectories of Alzheimer's disease (AD) patients. We performed a genome-wide association study to examine rate of cognitive decline (ROD) in patients with AD. METHODS: We tested for interactions between genetic variants and time since diagnosis to predict the ROD of a composite cognitive score in 3946 AD cases and performed pathway analysis on the top genes....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
